Table 3.

Tissue proportions for ALL cohort visits and controls.

	ALL Diagnosis (n=12)	ALL End of Induction (n=12)	ALL End of Delayed Intensification (n=12)	Controls (n=116)
DXA
Total body fat %	25.5 ± 10.4 (8.7, 40.0)	32.6 ± 8.8† ‡ (19.2, 44.9)	36.2 ± 8.5* † ‡ (20.0, 48.3)	28.1 ± 10.6 (8.0, 49.3)
CT
Bone (%)	15.2 ± 2.1* (11.6, 19.8)	16.2 ± 2.4* † (12.1, 19.7)	13.6 ± 2.9† ‡ (8.8, 20.0)	13.5 ± 2.1 (8.2, 19.0)
Muscle (%)	49.5 ± 7.6 (36.3, 58.9)	44.6 ± 6.9* † (30.4, 53.0)	45.8 ± 7.0* † (29.1, 53.2)	51.5 ± 7.0 (35.9, 67.2)
Total Adipose (%)	35.3 ± 9.0 (21.4, 52.1)	39.2 ± 8.9† (29.1, 57.4)	40.5 ± 9.0* † (30.6, 62.1)	35.1 ± 8.7 (16.2, 55.8)
SC Adipose (%)	33.8 ± 8.8 (20.0, 50.2)	37.6 ± 8.6† (27.1, 55.4)	38.4 ± 8.6* † (28.3, 59.1)	33.4 ± 8.4 (15.1, 53.5)
MA Adipose (%)	1.5 ± 0.7 (0.60, 2.8)	1.6 ± 0.65 (0.60, 2.9)	2.1 ± 0.85* † ‡ (0.95, 3.9)	1.6 ± 0.74 (0.61, 5.1)

All values presented at mean ± standard deviation (minimum value, maximum value). SC refers to subcutaneous; MA refers to muscle-associated.

^*different from control cohort at p<0.05

^†different from ALL V1 at p<0.05

^‡different from ALL V2 at p<0.05